Novartis acquires The Medicines Company for $9.7 billion

Swiss drug maker Novartis is betting on drugs to treat heart disease. The company is acquiring cholesterol drug maker "The Medicines Company" for $9.7 billion. John Maraganore, CEO of Alnylam Pharmaceuticals, joins "Squawk Box" to discuss.
05:34
Mon, Nov 25 20198:39 AM EST